期刊文献+

PI3K/PTEN/AKT/mTOR信号通道在胃癌有关组织中的表达及临床意义 被引量:1

Expression and clinical significance of the signal pathway PI3 K/PTEN/AKT/mTOR in related tissues of gastric carcinoma
原文传递
导出
摘要 目的研究PI3K/PTEN/AKT/mTOR信号通道在胃癌组织中的表达及临床意义。方法采用免疫组化sP法分别检测33例胃癌及30例正常胃组织中mTOR、FFEN的表达情况,并分析二者与性别、年龄、淋巴结转移、浸润深度和分化程度的关系。结果mTOR蛋白阳性反应产物主要分布于胞质,PTEN的蛋白阳性反应产物主要定位于胞核。将mTOR表达阴性,PTEN表达阳性为一组,与mTOR表达阳性而PTEN表达阴性为一组进行比较,发现对于不同的大体类型,组织学分型,二组间的差异有统计学意义(P〈0.05),对于不同的淋巴结转移,临床病理分期,二组问的差异有统计学意义(P〈0.01)。结论在PI3K/PTEN/AKT/mTOR信号通道中,mTOR与PTEN的联合表达可作为判断胃癌分期、判断预后的指标和化学治疗的靶点。 Objective To study the expression and clinical significance of the signal pathway PI3K/PTEN/AKT/mTOR in gastric carcinoma tissues. Methods The expression of mTOR and PTEN in 33 cases of gastric carcinoma and 30 cases of normal gastric tissue was detected by immunohistochemistry SP method respectively, and its relation with gender, age, tumor metastasis, the depth of invasion and differentiation analyzed. Results The positive product of the mTOR protein was mainly distributed in the endochylema, while the positive product of the PTEN protein mainly located in the nucleus. We regarded the negative roTOR with positive PTEN as one group, and negative PTEN with positive mTOR as the other group. It was found there was significant difference in different categories and histological types, different metastases, and clinical pathology stage between the two groups ( P 〈 0.01 or 0.05 ). Conclusion The expression of roTOR and PTEN is closely related in the signal pathway PI3K/PTEN/ AKT/mTOR. The combined expression of mTOR and PTEN can be used to justify staging of gastric carcinoma and the prognosis, and as a target of the chemotherapy.
出处 《临床外科杂志》 2009年第2期106-108,共3页 Journal of Clinical Surgery
基金 湖北省科技攻关项目(2005AA304804)
关键词 胃肿瘤 MTOR PTEN 免疫组织化学 gastric carcinoma mTOR PTEN immunohistochemistry
  • 相关文献

参考文献5

  • 1Zhou X,Tan M, Stone Hawthorne V, et al. Activation of the Akt/mammalian target of rapamycin/4E - BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers [ J ]. Clin Cancer Res,2004,10(20) :6779-6788.
  • 2刘民锋,罗剑,余险峰,唐启彬,陈勇军,邹声泉.PTEN和mTOR信号转导通路在胆管癌发展中作用的研究[J].中国普通外科杂志,2006,15(4):274-276. 被引量:13
  • 3郑杰.mTOR信号途径与肿瘤[J].生命科学,2006,18(3):261-265. 被引量:20
  • 4Jiang BH, Liu LZ. PI3 K/PTEN signaling in tumorigenesis and angiogenesis[ J]. Biochim Biophys Acta,2008,1784( 1 ) :150-158.
  • 5Cleary C, Linde JA, Hiscock KM. Antidepressive - like effects of rapamycin in animal models:Implications for mTOR inhibition as a new target for treatment of affective disorders[J].Brain Res Bull, 2008,76 ( 5 ) : 469-473.

二级参考文献29

  • 1Gao N,Zhang Z,Jiang BH,et al.Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer[J].Biochem Biophys Res Commun,2003,310(4):1124-1132.
  • 2Vogt PK.PI 3 -kinase,mTOR,protein synthesis and cancer[J].Trends Mol Med,2001,(7)11:482 -484.
  • 3Findlay GM,Harrington LS,Lamb RF.TSC-2 tumor suppressor and regulation of mTOR signaling:linking cell growth and proliferation?[J].Curr Opin Genet Dev,2005,15(1):69 -76.
  • 4Huang S,Houghtom PJ.Targeting mTOR signaling for cancer therapy[J].Curr Opin Phamacol,2003,3(4):371 -377.
  • 5Xu G,Zhang W,Bertram P,et al.Pharmacogenomic profiling of the PI3 K/PTEN-AKT-mTOR pathway in common human tumor[J].Int J Oncol,2004,24(4):901 -908.
  • 6Inoki K,Corradetti M N,Guan K L.Dysregulation of the TSC-mTOR pathway in human disease.Nat Genet,2005,37(1):19~24
  • 7Guertin D A,Sabatini D M.An expanding role for mTOR in cancer.Trends Mol Med,2005,11(8):353~361
  • 8Sarbassov D D,Guertin D A,Ali S M,et al.Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.Science,2005,307(5712):1098~1101
  • 9Hardie D G.The AMP-activated protein kinase pathwaynew players upstream and downstream.J Cell Sci,2004,117(Pt 23):5479~5487
  • 10Martin D E,Hall M N.The expanding TOR signaling network.Curr Opin Cell Biol,2005,17(2):158~166

共引文献31

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部